No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment

To study the differences in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding (EVB) and renal functional impairment (RFI). METHODS: The National Health Insurance Database, part of the Taiwan National Health Insurance Program, was used...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Gastroenterol Hepatol
Hlavní autoři: Hung, Tsung-Hsing, Tsai, Chen-Chi, Tseng, Chih-Wei, Tseng, Kuo-Chih, Hsieh, Yu-Hsi, Tsai, Chih-Chun
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams And Wilkins 2016
Témata:
Original Articles: Liver Failure
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051540/
https://ncbi.nlm.nih.gov/pubmed/27455080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MEG.0000000000000703
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky